About Kristin Fortney, Ph.D.
Dr. Kristen Fortney is the CEO and co-founder of BioAge, a clinical-stage biotechnology company whose mission is to develop a broad pipeline of therapies that target aging in order to increase healthspan and address chronic disease. Kristen draws from a deep background in aging research and systems biology to develop BioAge’s data-driven approach to identify and target the molecular pathways that drive aging. Kristen received her PhD in Medical Biophysics from the University of Toronto, followed by postdoctoral training at Stanford University. She has over 10 years of experience developing novel bioinformatics approaches for data-driven investigation into the mechanisms of aging and age-related disease, with over 20 published papers spanning computational drug discovery, biomarkers of aging, and the genetics of exceptional human longevity.
Related Organizations
